Senior Bioinformatician working across biology, data science, and therapeutic discovery.
My focus is on rigorous computational biology work, a strong translational research orientation, and a publication trail centered on regulatory RNA, oligonucleotide therapeutics, and disease-focused discovery.
The publication history exposes a consistent pattern: regulatory RNA, antisense oligonucleotide strategies, protein and gene upregulation, and disease programs spanning frontotemporal dementia, SynGAP1-related disorders, liver disease, and metabolic dysfunction.
Multiple visible papers center on modulating regulatory RNAs to alter downstream biological expression.
The record consistently references antisense oligos and oligonucleotide-based therapeutic approaches.
Visible work includes progranulin and SynGAP1-related disease contexts, linking computation with neurological therapeutics.
The through-line is translational: finding leverage points that can move from mechanism to intervention.
The public profile title and visible About section point to senior-level bioinformatics work within a leading cancer research environment.
Northeastern appears as the visible school affiliation, anchoring the academic side of the profile.
The visible certifications reinforce molecular biology depth and systems-thinking around biomolecular interaction analysis.
The public volunteer record adds a community dimension beyond research and institutional work.
These titles and venues are taken from the publicly visible LinkedIn profile snapshot. They are presented here as a clean reading view rather than a full academic bibliography.
A translational therapeutic angle combining regulatory RNA targeting with progranulin upregulation in the context of frontotemporal dementia.
A disease-focused extension of the progranulin work, framed in a neurodegeneration and oligonucleotide therapeutics setting.
A systems-level look at regulatory RNA around SynGAP1, with therapeutic upregulation as the intended translational outcome.
An example of the same RNA-targeting logic applied to hepatic biology and cholestatic liver disease.
A concise signal of repeated depth in oligonucleotide therapeutics and regulatory control mechanisms.
Work aligned with metabolic disease and gene-expression control, extending the profile beyond neurological programs.